Longying Jiang

5PUBLICATIONS
7CO-AUTHORS
Biologically active moleculesMolecular targetsContaminant hydrology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 18, 2025
A Hybrid compound H93 treats prostate cancer by directly binding UHRF1 and promoting protein dimerization.

Yuxin Fu, Longying Jiang, Guojian Xie

|Jul 18, 2023
Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity.

Hudie Wei, Haolan Wang, Genxin Wang

|Jan 25, 2023
Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants.

Qianmeng Lin, Xiaojuan Chen, Lingzhi Qu

|Jan 25, 2023
Structure-based design of a dual-warhead covalent inhibitor of FGFR4.

Xiaojuan Chen, Huiliang Li, Qianmeng Lin

|Oct 20, 2022
Structural insight into the ligand binding mechanism of aryl hydrocarbon receptor.

Shuyan Dai, Lingzhi Qu, Jun Li

Pageof 1